Bone TransplantationKidney TransplantationBone and BonesTransplantation, HomologousGraft SurvivalBone Marrow TransplantationGraft RejectionImmunosuppressive AgentsHematopoietic Stem Cell TransplantationTissue DonorsBone RemodelingTransplantsHistocompatibility TestingGraft vs Host DiseaseTransplantation ConditioningTransplantation, AutologousTime FactorsHematologic NeoplasmsRetrospective StudiesBone DensityTreatment OutcomePostoperative ComplicationsHeart TransplantationTransplantationBone ResorptionBone MarrowLung TransplantationBone Marrow CellsAcute DiseaseLiver TransplantationBone NeoplasmsBone DevelopmentRecurrenceBone DiseasesTissue and Organ ProcurementCyclosporineTacrolimusCombined Modality TherapyLiving DonorsWaiting ListsImmunosuppressionPost and Core TechniqueBone RegenerationCytomegalovirus InfectionsFetal Tissue TransplantationBone MatrixCadaverMycophenolic AcidTransplantation ImmunologyKidney Failure, ChronicImmunocompromised HostLiver FailureFollow-Up StudiesBone Diseases, MetabolicFractures, BoneBone SubstitutesRisk FactorsHeart-Lung TransplantationBrain Tissue TransplantationBronchiolitis ObliteransHistocompatibilityTransplantation, HeterotopicBone Morphogenetic ProteinsTransplantation ToleranceBiopsyOpportunistic InfectionsCytomegalovirusProspective StudiesSurvival AnalysisSurvival RateBK VirusBone Morphogenetic Protein 2OsteogenesisHLA AntigensKidneyAntilymphocyte SerumGanciclovirTransplantation, IsogeneicIsoantibodiesTemporal BoneLymphoproliferative DisordersPolyomavirus InfectionsWhole-Body IrradiationIncidenceCreatinineMice, Inbred C57BLKidney DiseasesEnd Stage Liver DiseaseLiver DiseasesFemurParietal BonePostoperative PeriodIslets of Langerhans TransplantationMycosesFatal OutcomeBiological Markers